Ryoji Yoshida

Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

Yoshihiro Yoshitake, Daiki Fukuma, Akira Yuno et al. · Clinical Cancer Research · 2014 · 153 citations · Full text

Medicine, Immunology, Oncology +17

IL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma

Yuichiro Matsuoka, Hideki Nakayama, Ryoji Yoshida et al. · British Journal of Cancer · 2016 · 127 citations · Full text

Medicine, Cancer Biology, Oncology +17

The pathological significance of Notch1 in oral squamous cell carcinoma

Ryoji Yoshida, Masashi Nagata, Hideki Nakayama et al. · Laboratory Investigation · 2013 · 117 citations

Veterinary Medicine, Oncology, Oral Pathology +14

Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma

Wael Abdo Hassan, Ryoji Yoshida, Shinji Kudoh et al. · Lung Cancer · 2014 · 111 citations

Life Sciences, Cell Biology, Oncology +14

FTO Demethylates Cyclin D1 mRNA and Controls Cell-Cycle Progression

Mayumi Hirayama, Fan‐Yan Wei, Takeshi Chujo et al. · Cell Reports · 2020 · 90 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17